The 15 dangerous diseases accounted for 50.7% of total serious harms and the top 5 (stroke, sepsis, pneumonia, venous thromboembolism and lung cancer) accounted for 38.7%. Conclusion An estimated 795 ...

Clinical trials frequently include multiple end points that mature at different times ... nonurothelial tract recurrence-free survival (NUTRFS), and distant metastasis-free survival (DMFS). 7 Here, we ...